Alpha-1 Antitrypsin Deficiency (AAT), sometimes known simply as “alpha-1”, is a genetic disease primarily affecting the lungs and liver. It is characterized by a decrease in circulating levels of a protein called alpha1 antitrypsin. AAT deficiency is the major known genetic risk factor for chronic obstructive pulmonary disease (COPD).

Join Dr. Lyle Melenka for this presentation on Alpha-1 Antitrypsin Deficiency.

About the Presenter: Dr. Lyle Melenka, MD, MSc., FRCPC

Dr. Lyle Melenka graduated from medical school in 1981. From there, he specialized in Internal Medicine and Respiratory Medicine; later obtaining his Master of Science (M.Sc.) degree in Epidemiology. He takes pride in having completed his education locally, at the prestigious University of Alberta, and has been a practicing Respirologist for the past 25 years.

Dr. Melenka’s work is recognized in countless publications and research projects. Dr. Melenka stays at the forefront of the pulmonary field by his involvement in various research projects, clinical trials, teaching conferences and occupational health programs.

This webinar is sponsored by Grifols.